Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis
Patrick Oeckl, Patrick Weydt, Dietmar Rudolf Thal, et al.
Acta Neuropathologica (2019) Vol. 139, Iss. 1, pp. 119-134
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Applications of multi‐omics analysis in human diseases
Chongyang Chen, Jing Wang, Donghui Pan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 172
Neurofilaments as biomarkers in neurological disorders — towards clinical application
Michael Khalil, Charlotte E. Teunissen, Sylvain Lehmann, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 5, pp. 269-287
Closed Access | Times Cited: 111
Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes
Jack Humphrey, Sanan Venkatesh, Rahat Hasan, et al.
Nature Neuroscience (2022) Vol. 26, Iss. 1, pp. 150-162
Open Access | Times Cited: 77
Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases
Artur Francisco Schumacher Schuh, Andrei Bieger, Wyllians Vendramini Borelli, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 45
Spatial Transcriptomics-correlated Electron Microscopy maps transcriptional and ultrastructural responses to brain injury
Peter Androvic, Martina Schifferer, Katrin Perez Anderson, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection
Fangjia Yang, Paula Beltran-Lobo, Katherine Sung, et al.
Science Advances (2024) Vol. 10, Iss. 12
Open Access | Times Cited: 10
Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases
Sára Mravinacová, Sofia Bergström, Jennie Olofsson, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis
Matija Zelic, Anna S. Blazier, Fabrizio Pontarelli, et al.
Immunity (2025)
Open Access | Times Cited: 1
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis
Samir Abu‐Rumeileh, Veria Vacchiano, Corrado Zenesini, et al.
Journal of Neurology (2020) Vol. 267, Iss. 6, pp. 1699-1708
Closed Access | Times Cited: 58
The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention
Stephanie M. Boas, Kathlene L. Joyce, Rita M. Cowell
Antioxidants (2021) Vol. 11, Iss. 1, pp. 8-8
Open Access | Times Cited: 44
Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson’s Disease
Rekha Raghunathan, Kathleen Turajane, Li Chin Wong
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9299-9299
Open Access | Times Cited: 37
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis
Yuri Falzone, Teuta Domi, Alessandra Mandelli, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 7, pp. 1930-1939
Open Access | Times Cited: 35
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
Marie Dreger, Robert Steinbach, Markus Otto, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 4, pp. 422-435
Open Access | Times Cited: 34
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Jared S. Katzeff, Fiona Bright, Katherine Phan, et al.
Brain (2022) Vol. 145, Iss. 5, pp. 1598-1609
Open Access | Times Cited: 33
Discovery of Biomarkers for Amyotrophic Lateral Sclerosis from Human Cerebrospinal Fluid Using Mass-Spectrometry-Based Proteomics
Sungtaek Oh, Yura Jang, Chan Hyun Na
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1250-1250
Open Access | Times Cited: 19
TDP-43 Proteinopathy Specific Biomarker Development
Isabell Cordts, Annika Wachinger, Carlo Scialò, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 597-597
Open Access | Times Cited: 17
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Fabiola De Marchi, Toni Franjkic, Paride Schito, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1599-1599
Open Access | Times Cited: 17
Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale
Nicolas Ruffini, Susanne Klingenberg, Susann Schweiger, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2642-2642
Open Access | Times Cited: 49
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease
Steffen Halbgebauer, Patrick Oeckl, Petra Steinacker, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 92, Iss. 4, pp. 349-356
Open Access | Times Cited: 46
From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis
Giovanna Morello, Salvatore Salomone, Velia D’Agata, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 44
Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers
Julia Remnestål, Linn Öijerstedt, Abbe Ullgren, et al.
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 40
Biomarkers for amyotrophic lateral sclerosis
Simon Witzel, Kristina Mayer, Patrick Oeckl
Current Opinion in Neurology (2022)
Closed Access | Times Cited: 24
A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer’s disease patients from controls
Ida Pesämaa, Stephan A. Müller, Sophie Robinson, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 14
Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion
Peggy Barschke, Patrick Oeckl, Petra Steinacker, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 5, pp. 503-511
Open Access | Times Cited: 39
The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?
Rangariroyashe H. Chipika, We Fong Siah, Mary Clare McKenna, et al.
Journal of Neurology (2020) Vol. 268, Iss. 12, pp. 4607-4629
Closed Access | Times Cited: 36
Page 1 - Next Page

Scroll to top